Bert Zbar
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
-
- Renal cell carcinoma treatment
Papers in
-
- Renal and related cancers 3
- Epigenetics and DNA Methylation 3
- Fibroblast Growth Factor Research 1
-
- Renal cell carcinoma treatment 3
- Co-authors
- Brett Delahunt (2 shared papers)Anke van den Berg (2 shared papers)L. Jeffrey Medeiros (2 shared papers)Gyula Kovács (2 shared papers)Stewart Fleming (2 shared papers)Stephan Störkel (2 shared papers)Colin S. Cooper (2 shared papers)Göran Roos (2 shared papers)
- Journals
- The Journal of Pathology (2 papers)Urology (1 paper)Journal of Clinical Investigation (1 paper)Human Genetics (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Bert Zbar
8 papers receiving 1.5k citations
Bert Zbar's Hit Papers
Peers
Comparison fields: 5 of 67
- Cancer Research 620
- Pulmonary and Respiratory Medicine 1.0k
- Molecular Biology 1.1k
- Oncology 261
- Surgery 259
Countries citing papers authored by Bert Zbar
This map shows the geographic impact of Bert Zbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Zbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Zbar more than expected).
Fields of papers citing papers by Bert Zbar
This network shows the impact of papers produced by Bert Zbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Zbar. The network helps show where Bert Zbar may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert Zbar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Heidelberg classification of renal cell tumours Hit paper breakdown → | 1997 | 1041 |
| 2 | 1994 | 118 | |
| 3 | 2007 | 106 | |
| 4 | 1999 | 86 | |
| 5 | 1997 | 67 | |
| 6 | 1997 | 64 | |
| 7 | 1981 | 19 | |
| 8 | 1993 | 7 |
About Bert Zbar
Bert Zbar is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 8 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Renal and related cancers (3 papers), Epigenetics and DNA Methylation (3 papers), Renal cell carcinoma treatment (3 papers), Cancer-related Molecular Pathways (2 papers), Genetic and Kidney Cyst Diseases (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Cancer Research (620 citations), Pulmonary and Respiratory Medicine (1.0k citations), Molecular Biology (1.1k citations), Oncology (261 citations) and Surgery (259 citations). Bert Zbar has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Brett Delahunt, Anke van den Berg, L. Jeffrey Medeiros, Gyula Kovács, Stewart Fleming, Stephan Störkel, Colin S. Cooper, Göran Roos, John R. Srigley and Börje Ljungberg. Their work appears in journals such as The Journal of Pathology, Urology, Journal of Clinical Investigation, Human Genetics and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.